$ARNA Recent News Arena shares surge as marketer doubles

New Post Public Reply Private Reply Replies (0) Message Board

Nov 8, 2013 at 7:05 PM

$ARNA Recent News

Arena shares surge as marketer doubles sales force for diet drug 11:41 a.m. Oct. 15, 2013 - Russ Britt
Obesity drug makers jockey for position as analysts praise Vivus 12:06 p.m. Oct. 3, 2013 - Russ Britt
Hedge funds are buying these stocks right now 1:46 p.m. July 23, 2013 - Insider Monkey
5 stocks insiders are buying 1:52 p.m. June 7, 2013 - Insider Monkey
6 gut checks before the stock market's opening bell 6:47 a.m. March 7, 2013 - Shawn Langlois
Stocks to watch Monday: Transocean, Stratasys 9:22 a.m. March 4, 2013 - Sue Chang
Arena Pharmaceuticals down 7.4% in premarket 9:11 a.m. Jan. 22, 2013 - Steve Gelsi
What 2012’s winners and losers say about 2013 6:00 a.m. Dec. 14, 2012 - Howard Gold
6 gut checks before the stock market's opening bell 6:50 a.m. Dec. 12, 2012 - Shawn Langlois
4 charts challenging resistance 7:06 a.m. Oct. 16, 2012 - The Trading Deck
Vivus sees EU regulators rejecting diet drug 12:16 p.m. Sept. 21, 2012 - MarketWatch.com
Vivus falls 11% on EU drug approval update 11:07 a.m. Sept. 21, 2012 - Val Brickates Kennedy
Arena rises as Vivus sees anti-obesity setback 7:49 a.m. Sept. 21, 2012 - Greg Morcroft
Vivus says Europe likely to reject obesity drug 7:33 a.m. Sept. 21, 2012 - MarketWatch.com
Orexigen soars 19% on analyst buy rating 12:46 p.m. Sept. 6, 2012 - Val Brickates Kennedy
Arena jumps 12% amid takeover speculation 1:55 p.m. Aug. 14, 2012 - Val Brickates Kennedy
Arena trips Nasdaq short-sale circuit breaker 3:01 p.m. Aug. 1, 2012 - Val Brickates Kennedy
Arena Pharma share drop trips short-sale limit 2:16 p.m. Aug. 1, 2012 - Laura Mandaro
Eisai gears up for launch of Arena's diet drug 9:32 a.m. July 30, 2012 - Val Brickates Kennedy
Apple, Arena active; Lumber Liquidators at new high 9:06 a.m. July 25, 2012 - blogs.marketwatch.com

Arena Pharma Q3 Loss Narrower than Expected - Analyst Blog 5:00 p.m. Today - Zacks.com
U.S. Judge Orders Ex-Morgan Staney Adviser to Return Data and 2 Heavily Traded Stocks to Follow 3:59 p.m. Today - Wall St. Cheat Sheet
VIVUS Loss In Line with Ests, Shares Fall - Analyst Blog 4:45 p.m. Nov. 7, 2013 - Zacks.com
Arena Pharmaceuticals, Eisai Expand Marketing and Supply Agreement for BELVIQ 3:03 p.m. Nov. 7, 2013 - benzinga.com
Arena's Belviq Refills - Week 20 12:43 a.m. Nov. 5, 2013 - Seeking Alpha
Arena Pharmaceuticals - Belviq OTC? 3:09 a.m. Nov. 4, 2013 - Seeking Alpha
Arena's Belviq - Week 20 Sales Data 1:28 p.m. Nov. 1, 2013 - Seeking Alpha
Arena Stock Reacts To Eisai Quarterly Call 10:26 a.m. Nov. 1, 2013 - Seeking Alpha
Should You Worry About the Short Interest in Arena Pharmaceuticals, Inc. (ARNA)? - Tale of the Tape 9:59 a.m. Nov. 1, 2013 - Zacks.com
Benzinga's Top #PreMarket Losers 7:13 a.m. Nov. 1, 2013 - benzinga.com
Uh Oh Arena Pharma! Q3 Belviq Sales Just $4.8M 7:09 a.m. Nov. 1, 2013 - TheStreet.com
A Look Back At Biotech Short Picks 2:18 p.m. Oct. 31, 2013 - Seeking Alpha
Interesting ARNA Put And Call Options For December 6th 10:46 a.m. Oct. 31, 2013 - TheStreet.com
Arena's Belviq Refills Week 19 3:29 a.m. Oct. 30, 2013 - Seeking Alpha
Latent Disconnect Between Arena's Fundamentals And Valuation 3:33 p.m. Oct. 29, 2013 - Seeking Alpha
Arena's Belviq Sales: Week 19 11:19 a.m. Oct. 25, 2013 - Seeking Alpha
November 29th Options Now Available For Arena Pharmaceuticals (ARNA) 11:15 a.m. Oct. 24, 2013 - TheStreet.com
Arena's Belviq Refills - Week 18 Data 4:26 p.m. Oct. 22, 2013 - Seeking Alpha
Arena's Belviq Sales Flat - Equity Holds 11:11 a.m. Oct. 18, 2013 - Seeking Alpha
Arena Pharmaceuticals, Inc. Enters Oversold Territory - Tale of the Tape 6:01 a.m. Oct. 18, 2013 - Zacks.com

Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2013 Financial Results 4:10 p.m. Nov. 7, 2013 - PR Newswire
Arena Pharmaceuticals and Eisai Expand Marketing and Supply Agreement for BELVIQ® (lorcaserin HCl) to Include Most Countries Worldwide 4:02 p.m. Nov. 7, 2013 - PR Newswire
FDA Approvals, Successful Product Launches, Upcoming Earnings Schedules and Quarterly Financial Results - Research Report on Pfizer, Mettler-Toledo, Arena, Wright Medical, and Ophthotech 8:00 a.m. Nov. 7, 2013 - PR Newswire
Must Watch Stock News: Arena Pharmaceuticals, Hewlett-Packard Company, Resorts International, Alpha Natural Resources, Chevron Corporation 1:56 p.m. Nov. 4, 2013 - PR Newswire
Pre-Market Review: Arena Pharma Inc., Geron Corp., Incyte Corp. Ltd, and Spectrum Pharma Inc. 9:00 a.m. Oct. 31, 2013 - PR Newswire
Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, November 7 8:00 a.m. Oct. 30, 2013 - PR Newswire
Sales Strategies, Upcoming Financial Results Schedules, Clinical Study Updates, and FDA Agreements - Research Report on Arena, Seattle Genetics, Halozyme, Insmed, and Omeros 8:00 a.m. Oct. 21, 2013 - PR Newswire
Arena Pharmaceuticals Reports That Eisai Will Double BELVIQ® (lorcaserin HCl) CIV Sales Force by December 9:03 a.m. Oct. 15, 2013 - PR Newswire
Early Briefing and Review: Arena Pharma Inc., Spectrum Pharma Inc., Incyte Corp. Ltd., and Geron Corp. 9:26 a.m. Oct. 8, 2013 - PR Newswire
Drug Approvals, Data Presentations, Conferences, Increased Funding, and Merger Agreements - Research Report on Theravance, Arena, Exelixis, Verenium, and Enanta 8:00 a.m. Sept. 25, 2013 - PR Newswire
Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 8:00 a.m. Sept. 23, 2013 - PR Newswire
Arena Pharmaceuticals to Present Clinical Data for BELVIQ® (lorcaserin HCl) CIV at the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD) 8:00 a.m. Sept. 18, 2013 - PR Newswire
Arena Pharmaceuticals Provides Update as Eisai's Launch of BELVIQ® (lorcaserin HCl) CIV Enters Consumer Phase 8:00 a.m. Sept. 16, 2013 - PR Newswire
Track Insider Trading in Facebook, Zynga, Arena Pharmaceuticals, Lululemon Athletica, Weatherford International, and Bank of America 8:55 a.m. Sept. 13, 2013 - PR Newswire
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARIA, ARNA, EXEL and OREX 9:05 a.m. Sept. 11, 2013 - ACCESSWIRE
Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch Global Healthcare Conference 8:00 a.m. Sept. 6, 2013 - PR Newswire
Successful Clinical Trials, Data Presentations, Promising Studies, Fulfilled Agreements and Investors Conferences - Research Report on Arena, BioMarin, Clovis Oncology, MannKind, and Medivation 8:00 a.m. Sept. 3, 2013 - PR Newswire
Five Star Equities Issues New Research Reports on ARNA, COCO, CWST and GES 8:40 a.m. Aug. 30, 2013 - ACCESSWIRE
Arena Pharmaceuticals Completes Phase 1b Clinical Trial Evaluating APD811 for Pulmonary Arterial Hypertension 8:00 a.m. Aug. 28, 2013 - PR Newswire
Innovus Pharma Provides Corporate Update 6:30 a.m. Aug. 19, 2013 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mount St. Mary's Expands Pathways with SJR MOU

Catholic Education Steps Up the Game You know, it’s not every day you bump into a move that feels like a real win-win in the education sector. But here we are, watching this shiny new partnership between Mount St. Mary's University and Saint Joseph Regional High School unfold. The pair signed a fresh memorandum of understanding (MOU) that’s got everyone...

Mohegan Sun Arena's $30M Overhaul Elevates Experiences

Mohegan Sun Aims for New Heights with Major Overhaul Tuck into this: Mohegan Sun Arena, that entertainment juggernaut nestled in Montville, is gearing up for a massive $30 million facelift. You're talking all-new seating, cutting-edge concessions, and premium hospitality that puts other venues to shame. Over Two Decades of Entertainment Excellence This isn’t just...

PPL Reports Strong Q3; Long-Term EPS Growth Up

Solid Earnings in a Challenging Market Anytime you start hearing a company like PPL boasting about their quarterly earnings, it's time to sit up straight and pay attention. The utility giant didn’t just match expectations, they beat 'em, clocking in with $0.54 per share in ongoing earnings for Q3 2026, up from $0.48 the previous year. Not a bad step forward if you ask...

U Power's H1 2026: Inside the Financial Numbers

Financial Struggles Amid Expansion Efforts Imagine a ship trying to lift anchor while taking on water. That's U Power Limited's latest financials for the first half of 2026 in a nutshell. We're seeing the company, listed under NASDAQ: UCAR, navigating through turbulent financial seas while executing ambitious expansion projects. Revenue Declines Spell Trouble Total net...

Maritime Injury Law: Neidzwski Talks Sea Changes

Legal waters are as choppy as the seas themselves, especially in the maritime injury law arena. Nicholas J. Neidzwski, a maritime injury attorney and partner at BoatLaw, LLP, recently waded into these turbulent waters at the 2026 Pacific Admiralty Seminar. This isn’t just any gathering; it’s the West Coast’s legal beacon on all things maritime, drawing in industry...

Frederick Foundation Welcomes New Leaders for Growth

Stirring the Philanthropic Pot in Frederick Moving pieces around the community chessboard once again, the Community Foundation of Frederick County brings in fresh minds—and the stakes have never been higher for these charitable endeavors. They've just put RaeAnn E. Butler at the helm, an established presence who’s now the primary captain steering this ship. Come...

Tiana Marbuery Joins ALTA Division at Partner

Tiana Marbuery Dives In at Partner Forget flashy office parties and buzzword bingo. Today’s gig's all about substance. Partner Engineering and Science, Inc. just snagged themselves a heavy-hitter with Tiana Marbuery joining the ranks as Technical Director in their ALTA Division. This ain't a small fry deal—Marbuery's packing over eight years of hard-earned chops in...

Blue Friday Sales: A Princess Cruises' Steal

By Caleb Price Updated Nov 6, 2026 Category News Views 109

Setting Sail on Savings: Princess Cruises' Offerings When folks start talking about Black Friday, you probably think of TVs or gadgets, but Princess Cruises is flipping that idea with their 'Blue Friday' sale, running from November 6 through December 7, 2026. Now, cruises aren't your traditional doorbuster, but a vacation might just be the kind of experience worth...

Tetragon Declares Dividend Amidst Regulation Challenges

What Keeps Investors on Their Toes Tetragon Financial Group is ringing the dividend bell again—a solid 12 cents a share coming your way. But don't just kick your feet up and watch the cash roll in; there's a tangle of juicy tidbits and regulatory strings attached that make this more than your run-of-the-mill payout announcement. A Look at the Dividend Breakdown For...

Leadership Key in Global Long-Term Care Standards

A Call for Leadership Recognition Yeah, leadership is vital, but try telling that to a global body like the WHO without getting your requests bogged down in a sea of bureaucracy. The National Association of Long Term Care Administrator Boards (NAB) and the American College of Health Care Administrators (ACHCA) sure have their work cut out. They've petitioned the WHO to...